These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38694208)

  • 21. The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression.
    Pawar A; Botolin D; Mangelsdorf DJ; Jump DB
    J Biol Chem; 2003 Oct; 278(42):40736-43. PubMed ID: 12917410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirt1 counteracts decrease in membrane phospholipid unsaturation and diastolic dysfunction during saturated fatty acid overload.
    Yamamoto T; Endo J; Kataoka M; Matsuhashi T; Katsumata Y; Shirakawa K; Yoshida N; Isobe S; Moriyama H; Goto S; Yamashita K; Ohto-Nakanishi T; Nakanishi H; Shimanaka Y; Kono N; Shinmura K; Arai H; Fukuda K; Sano M
    J Mol Cell Cardiol; 2019 Aug; 133():1-11. PubMed ID: 31145942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. n-3 fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice.
    Jung UJ; Millman PN; Tall AR; Deckelbaum RJ
    Biochim Biophys Acta; 2011 Sep; 1811(9):491-7. PubMed ID: 21704188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.
    Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
    Cell Physiol Biochem; 2016; 39(1):350-9. PubMed ID: 27352290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements.
    Yoshikawa T; Shimano H; Yahagi N; Ide T; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Takahashi A; Sone H; Osuga Ji J; Gotoda T; Ishibashi S; Yamada N
    J Biol Chem; 2002 Jan; 277(3):1705-11. PubMed ID: 11694526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
    Green CD; Jump DB; Olson LK
    Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
    Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
    Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression.
    Seo JB; Moon HM; Kim WS; Lee YS; Jeong HW; Yoo EJ; Ham J; Kang H; Park MG; Steffensen KR; Stulnig TM; Gustafsson JA; Park SD; Kim JB
    Mol Cell Biol; 2004 Apr; 24(8):3430-44. PubMed ID: 15060163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of liver X receptor promotes fatty acid synthesis in goat mammary epithelial cells via modulation of SREBP1 expression.
    Xu HF; Luo J; Zhang XY; Li J; Bionaz M
    J Dairy Sci; 2019 Apr; 102(4):3544-3555. PubMed ID: 30738675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes.
    Volle DH; Repa JJ; Mazur A; Cummins CL; Val P; Henry-Berger J; Caira F; Veyssiere G; Mangelsdorf DJ; Lobaccaro JM
    Mol Endocrinol; 2004 Apr; 18(4):888-98. PubMed ID: 14739254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.
    Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LXR agonist T0901317 upregulates thrombomodulin expression in glomerular endothelial cells by inhibition of nuclear factor‑κB.
    Ding H; Li Y; Feng Y; Chen J; Zhong X; Wang N; Wang W; Zhang P; Wang L
    Mol Med Rep; 2016 Jun; 13(6):4888-96. PubMed ID: 27082844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
    Cha JY; Repa JJ
    J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Role of Liver X Receptor (LXR)
    Hansmann E; Mennillo E; Yoda E; Verreault M; Barbier O; Chen S; Tukey RH
    Drug Metab Dispos; 2020 Apr; 48(4):255-263. PubMed ID: 31980500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
    Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
    J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.
    Beyer C; Huang J; Beer J; Zhang Y; Palumbo-Zerr K; Zerr P; Distler A; Dees C; Maier C; Munoz L; Krönke G; Uderhardt S; Distler O; Jones S; Rose-John S; Oravecz T; Schett G; Distler JH
    Ann Rheum Dis; 2015 Jun; 74(6):1317-24. PubMed ID: 24618263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.
    Denechaud PD; Bossard P; Lobaccaro JM; Millatt L; Staels B; Girard J; Postic C
    J Clin Invest; 2008 Mar; 118(3):956-64. PubMed ID: 18292813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
    Chonlaket P; Wongwan T; Soodvilai S
    Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.
    Laffitte BA; Chao LC; Li J; Walczak R; Hummasti S; Joseph SB; Castrillo A; Wilpitz DC; Mangelsdorf DJ; Collins JL; Saez E; Tontonoz P
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5419-24. PubMed ID: 12697904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.